CHASE THERAPEUTICS CORP

Profile

Company Names

CHASE THERAPEUTICS CORP

Addresses

1825 K STREET NW, SUITE 510, WASHINGTON, DC 20006

1825 K STREET NW, SUITE 520, WASHINGTON, DC 20006

Phone Numbers

202-223-7002

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$5,300,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-08-21 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
1
2017-11-17 
$1,300,000.00 
$1,300,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
N. 
CHASE 
EXECUTIVE OFFICER, DIRECTOR
CHASE PHARMACEUTICALS CORP   |  CHASE THERAPEUTICS CORP
KATHLEEN 
 
CLARENCE-SMITH 
DIRECTOR
CHASE PHARMACEUTICALS CORP   |  GT BIOPHARMA, INC.   |  CHASE THERAPEUTICS CORP
RICHARD 
P. 
DULIK 
EXECUTIVE OFFICER
CHASE PHARMACEUTICALS CORP   |  CHASE THERAPEUTICS CORP
KAROLY 
 
NIKOLICH 
DIRECTOR
EXCELIMMUNE, INC   |  CHASE PHARMACEUTICALS CORP   |  ALKAHEST, INC.   |  CHROMADERM, INC.   |  BIOMMUNE TECHNOLOGIES INC.   |  CHASE THERAPEUTICS CORP   |  LUCY THERAPEUTICS, INC.
JOHN 
 
REHER 
DIRECTOR
CHASE THERAPEUTICS CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-08-28
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-21 
2017-11-29
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#